Acer Medical Statistics
Total Valuation
Acer Medical has a market cap or net worth of TWD 1.75 billion. The enterprise value is 1.57 billion.
Market Cap | 1.75B |
Enterprise Value | 1.57B |
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025.
Earnings Date | Nov 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Acer Medical has 15.23 million shares outstanding.
Current Share Class | 15.23M |
Shares Outstanding | 15.23M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 4.78% |
Owned by Institutions (%) | 0.54% |
Float | 3.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 31.78 |
PB Ratio | 9.76 |
P/TBV Ratio | 9.95 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -51.74 |
EV / Sales | 28.47 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -65.35 |
Financial Position
The company has a current ratio of 6.76
Current Ratio | 6.76 |
Quick Ratio | 6.54 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.58% and return on invested capital (ROIC) is -10.64%.
Return on Equity (ROE) | -15.58% |
Return on Assets (ROA) | -9.13% |
Return on Invested Capital (ROIC) | -10.64% |
Return on Capital Employed (ROCE) | -18.46% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 22 |
Asset Turnover | 0.24 |
Inventory Turnover | 3.10 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.32% in the last 52 weeks. The beta is 1.15, so Acer Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.15 |
52-Week Price Change | -25.32% |
50-Day Moving Average | 116.66 |
200-Day Moving Average | 129.98 |
Relative Strength Index (RSI) | 51.69 |
Average Volume (20 Days) | 980 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acer Medical had revenue of TWD 55.10 million and -30.32 million in losses. Loss per share was -1.99.
Revenue | 55.10M |
Gross Profit | 32.85M |
Operating Income | -33.12M |
Pretax Income | -30.32M |
Net Income | -30.32M |
EBITDA | -32.59M |
EBIT | -33.12M |
Loss Per Share | -1.99 |
Balance Sheet
The company has 182.27 million in cash and n/a in debt, giving a net cash position of 182.27 million or 11.97 per share.
Cash & Cash Equivalents | 182.27M |
Total Debt | n/a |
Net Cash | 182.27M |
Net Cash Per Share | 11.97 |
Equity (Book Value) | 179.45M |
Book Value Per Share | 11.79 |
Working Capital | 172.94M |
Cash Flow
In the last 12 months, operating cash flow was -23.62 million and capital expenditures -386,000, giving a free cash flow of -24.01 million.
Operating Cash Flow | -23.62M |
Capital Expenditures | -386,000 |
Free Cash Flow | -24.01M |
FCF Per Share | -1.58 |
Margins
Gross margin is 59.62%, with operating and profit margins of -60.11% and -55.03%.
Gross Margin | 59.62% |
Operating Margin | -60.11% |
Pretax Margin | -55.03% |
Profit Margin | -55.03% |
EBITDA Margin | -59.15% |
EBIT Margin | -60.11% |
FCF Margin | n/a |
Dividends & Yields
Acer Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1.73% |
FCF Yield | -1.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Acer Medical has an Altman Z-Score of 43.47 and a Piotroski F-Score of 3.
Altman Z-Score | 43.47 |
Piotroski F-Score | 3 |